semaglutide pharmacokinetics subcutaneous Absorption, metabolism and excretion of the GLP-1 analogue in humans and nonclinical species Semaglutide is a FDA-approved GLP-1

Another option would be if the person responds to risperidone and it's a beautiful response and they have no side effects and they really don't want to change and you don't want to change because they've had a great antipsychotic response to the drug or great behavioral response (for example, in autism), you can give them a dopamine agonist to compete with the drug in the pituitary and see if you can bring down their prolactin

10.1097/MOG.0b013e3283505a3b 17

In the SELECT trial, 16.60% of participants taking Wegovy withdrew from the trial because of adverse events (AEs)

PengXWangXShaoXWangYFengSWangCet al

doi: 10.1136/ard-2023-224148